A detailed history of Conning Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Conning Inc. holds 10,648 shares of BSX stock, worth $890,385. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,648
Previous 10,759 1.03%
Holding current value
$890,385
Previous $828,000 7.73%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$72.96 - $84.0 $8,098 - $9,324
-111 Reduced 1.03%
10,648 $892,000
Q2 2024

Jul 26, 2024

BUY
$67.33 - $77.71 $27,739 - $32,016
412 Added 3.98%
10,759 $828,000
Q1 2024

Apr 26, 2024

SELL
$57.6 - $68.62 $13,824 - $16,468
-240 Reduced 2.27%
10,347 $708,000
Q4 2023

Jan 29, 2024

BUY
$48.64 - $57.81 $3,161 - $3,757
65 Added 0.62%
10,587 $612,000
Q3 2023

Oct 26, 2023

SELL
$50.19 - $54.68 $7,026 - $7,655
-140 Reduced 1.31%
10,522 $555,000
Q2 2023

Jul 21, 2023

SELL
$49.72 - $54.64 $74,580 - $81,960
-1,500 Reduced 12.33%
10,662 $576,000
Q1 2023

Apr 27, 2023

SELL
$45.09 - $50.03 $3,111 - $3,452
-69 Reduced 0.56%
12,162 $608,000
Q4 2022

Feb 07, 2023

SELL
$39.56 - $47.22 $1,068 - $1,274
-27 Reduced 0.22%
12,231 $566,000
Q3 2022

Oct 28, 2022

SELL
$36.71 - $109.66 $106,202 - $317,246
-2,893 Reduced 19.09%
12,258 $475,000
Q2 2022

Jul 20, 2022

SELL
$35.24 - $47.1 $4,017 - $5,369
-114 Reduced 0.75%
15,151 $565,000
Q1 2022

May 02, 2022

BUY
$40.9 - $45.1 $15,542 - $17,138
380 Added 2.55%
15,265 $676,000
Q4 2021

Jan 27, 2022

BUY
$38.07 - $44.87 $69,858 - $82,336
1,835 Added 14.06%
14,885 $632,000
Q3 2021

Nov 05, 2021

SELL
$41.23 - $45.88 $177,247 - $197,238
-4,299 Reduced 24.78%
13,050 $566,000
Q2 2021

Jul 29, 2021

SELL
$38.58 - $44.24 $64,891 - $74,411
-1,682 Reduced 8.84%
17,349 $742,000
Q1 2021

Apr 23, 2021

SELL
$35.27 - $39.67 $60,311 - $67,835
-1,710 Reduced 8.24%
19,031 $736,000
Q4 2020

Jan 28, 2021

SELL
$33.15 - $41.97 $13,889 - $17,585
-419 Reduced 1.98%
20,741 $746,000
Q3 2020

Oct 21, 2020

BUY
$34.44 - $42.23 $13,431 - $16,469
390 Added 1.88%
21,160 $809,000
Q2 2020

Aug 07, 2020

BUY
$30.19 - $39.11 $37,979 - $49,200
1,258 Added 6.45%
20,770 $729,000
Q1 2020

Apr 29, 2020

SELL
$25.83 - $45.71 $13,612 - $24,089
-527 Reduced 2.63%
19,512 $637,000
Q4 2019

Jan 29, 2020

SELL
$37.87 - $45.37 $30,295 - $36,296
-800 Reduced 3.84%
20,039 $906,000
Q3 2019

Oct 30, 2019

SELL
$40.31 - $43.45 $98,719 - $106,409
-2,449 Reduced 10.52%
20,839 $848,000
Q2 2019

Jul 25, 2019

SELL
$34.91 - $42.98 $123,232 - $151,719
-3,530 Reduced 13.16%
23,288 $1 Million
Q1 2019

Apr 22, 2019

BUY
$32.91 - $40.75 $4,278 - $5,297
130 Added 0.49%
26,818 $1.03 Million
Q4 2018

Jan 29, 2019

SELL
$31.73 - $39.04 $87,574 - $107,750
-2,760 Reduced 9.37%
26,688 $943,000
Q3 2018

Oct 26, 2018

SELL
$32.83 - $38.63 $59,520 - $70,036
-1,813 Reduced 5.8%
29,448 $1.13 Million
Q2 2018

Jul 25, 2018

SELL
$26.84 - $34.32 $30,060 - $38,438
-1,120 Reduced 3.46%
31,261 $1.02 Million
Q1 2018

May 04, 2018

BUY
$25.2 - $28.54 $756 - $856
30 Added 0.09%
32,381 $885,000
Q4 2017

Jan 30, 2018

SELL
$24.79 - $29.8 $18,840 - $22,648
-760 Reduced 2.3%
32,351 $802,000
Q3 2017

Oct 20, 2017

BUY
$26.26 - $29.17 $869,494 - $965,847
33,111
33,111 $966,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Conning Inc. Portfolio

Follow Conning Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.